Vivace Therapeutics rallies $30m Series C

Vivace Therapeutics, Inc, a small molecule discovery and development company, has secured $30 million in Series C financing.

Vivace Therapeutics, Inc, a small molecule discovery and development company, has secured $30 million in Series C financing. Boxer Capital led the round with participation from RA Capital Management and Canaan Partners.

Source: Press Release